Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer

Biochemistry (Moscow)

Volumn 69, Issue 1, 2004, Pages 23-31

  Shvedova, A A ^a,b   Kisin, E R ^a   Murray, A ^b   Kommineni, C ^a   Vallyathan, V ^a   Castranova, V ^a,b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Cumene hydroperoxide; Oxidative stress; Skin; Tumor promotion

Indexed keywords

ANTIOXIDANTS; CARCINOGENS; FREE RADICALS; METABOLISM; PHOTOCHEMICAL REACTIONS; STRESS ANALYSIS; TUMORS;

12-O-TETRADECANOYLPHORBOL-13-ACETATE; CUMENE HYDROPEROXIDE; OXIDATIVE STRESS; TUMOR PROMOTION;

SKIN;

MURINAE;

ANTIOXIDANT; BENZENE DERIVATIVE; CUMENE HYDROPEROXIDE; CYCLOOXYGENASE 2; ENZYME INHIBITOR; GLUTATHIONE; ISOENZYME; MEMBRANE PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; THIOL DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; KERATINOCYTE; LIPID PEROXIDATION; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; SENSITIVE TO CARCINOGENESIS MOUSE; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; BENZENE DERIVATIVES; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INHIBITORS; FEMALE; GLUTATHIONE; HUMANS; INFLAMMATION; ISOENZYMES; KERATINOCYTES; LIPID PEROXIDATION; MEMBRANE PROTEINS; MICE; MICE, INBRED SENCAR; OXIDATIVE STRESS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SKIN NEOPLASMS; SULFHYDRYL COMPOUNDS; TETRADECANOYLPHORBOL ACETATE;

EID: 3543147333     PISSN: 00062979     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BIRY.0000016347.35373.39     Document Type: Conference Paper

References (39)

1. Stratton, S. P., Dorr, R. T., and Alberts, D. S. (2000) Eur. J. Cancer, 36, 1292-1297.
2. Lewis, R. J. (1993) Hawley's Condensed Chemical Dictionary, 12th Ed., Van Nostrand Reinhold, New York, p. 133.
3. Ward, D. J. (1993) in Encyclopedia of Chemical Technology (Kirk-Othmer, J., ed.) Vol. 7, Academic Press, N. Y., pp. 730-736.
4. Hathaway, G. J., Proctor, N. H., and Hughes, J. P. (1996) in Proctor and Hughes' Chemical Hazards of the Workplace, 4th Ed., Van Nostrand Reinhold, New York, pp. 169-170.
5. Adams, R. M. (1999) in Occupational Skin Disease (Adams, R. M., ed.) W. B. Saunders, Philadelphia, PA, pp. 491-500.
6. Kensler, T. W., and Taffe, B. G. (1986) Adv. Free Rad. Biol. Med., 2, 347-387.
7. Nishi, J., Ogura, R., Sugiyama, M., Hidaka, T., and Kohno, M. (1991) J. Invest. Dermatol., 97, 115-119.
8. Yagi, K. (1988) in The Biological Role of Reactive Oxygen Species in Skin, University of Tokyo Press, Tokyo, pp. 109-116.
9. Shvedova, A. A., Kisin, E. R., Murray, A. R., Kommineni, C., Castranova, V., Mason, R. P., Kadiiska, M. B., and Gunther, M. R. (2002) Chem. Res. Toxicol., 15, 1451-1459.
10. Slaga, T. J., Klein-Szanto, A. J., Triplett, L. L., Yotti, L. P., and Trosko, K. E. (1981) Science, 213, 1023-1025.
11. Gimenez-Conti, I. B., Binder, R. L., Johnston, D., and Slaga, T. J. (1998) Toxicol. Appl. Pharmacol., 149, 73-79.
12. Vessey, D. A., Lee, K. H., and Blacker, K. L. (1992) J. Invest. Dermatol., 99, 859-863.
13. Vessey, D. A., Lee, K. H., and Boyer, T. D. (1995) J. Invest. Dermatol., 104, 355-358.
14. Babich, H., Zuckerbraun, H. L., Wurzburger, B. J., Rubin, Y. L., Borenfreund, E., and Blau, L. (1996) Toxicology, 106, 187-196.
15. Shvedova, A. A., Tyurina, Y. Y., Kawai, K., Tyurin, V. A., Kommineni, C., Castranova, V., Fabisiak, J. P., and Kagan, V. E. (2002) J. Invest. Dermatol., 118, 1008-1018.
16. Taffe, B. G., Zweier, J. L., Pannell, L. K., and Kensler, T. W. (1989) Carcinogenesis, 10, 1261-1268.
17. Timmins, G. S., and Davis, M. J. (1993) J. Photochem. Photobiol. B, 21, 167-173.
18. Kensler, T., Guyton, K., Egner, P., McCarthy, T., Lesko, S., and Akman, S. (1995) Progr. Clin. Biol. Res., 391, 103-116.
19. Klein-Szanto, A. J., and Slaga, T. J. (1982) J. Invest. Dermatol., 79, 30-34.
20. Nonaka, T., Mio, M., Doi, M., and Tasaka, K. (1992) Biochem. Pharmacol., 44, 1115-1121.
21. Buege, J. A., and Aust, S. D. (1978) Meth. Enzymol., 52, 302-310.
22. Niki, E. (1990) Meth. Enzymol., 186, 100-108.
23. Shvedova, A. A., Kommineni, C., Jeffries, B. A., Castranova, V., Tyurina, Y. Y., Tyurin, V. A., Serbinova, E. A., Fabisiak, J. P., and Kagan, V. E. (2000) J. Invest. Dermatol., 114, 354-364.
24. Bowden, G. T., Finch, J., Domann, F., and Krieg, P. (1995) in Skin Cancer: Mechanisms and Human Relevance (Mukhtar, H., ed.) CRC Press, Inc., Boca Raton, FL, pp. 99-111.
25. Hennings, H., Glick, A. B., Lowry, D. T., Krsmanovic, L. S., Sly, L. M., and Yuspa, S. H. (1993) Carcinogenesis, 14, 2353-2358.
26. Perchellet, J. P., Abney, N. L., Thomas, R. M., Perchellet, E. M., and Maatta, E. A. (1987) Cancer Res., 47, 6302-6309.
27. Solanki, V., Rana, R. S., and Slaga, T. J. (1981) Carcinogenesis, 2, 1141-1146.
28. Amstad, P. A., Liu, H., Ichimiya, M., Berezesky, I. K., and Trump, B. F. (1997) Carcinogenesis, 18, 479-484.
29. Isbir, T., Yaylim, L., Aydin, M., Ozturk, O., Koyuncu, H., Zeybek, U., Agachan, B., and Yilmaz, H. (2000) Anticancer Res., 20, 219-224.
30. Ames, B. N., Gold, L. S., and Willett, W. C. (1995) Proc. Natl. Acad. Sci. USA, 92, 5258-5265.
31. Bhasin, G., Kausar, H., Sarwar, A. M., and Athar, M. (2003) Arch. Biochem. Biophys., 409, 262-273.
32. Ohshima, H., and Bartsch, H. (1994) Mutat. Res., 305, 253-264.
33. Berhane, T., Halliday, G. M., Cooke, B., and Barnetson, R. S. (2002) Br. J. Dermatol, 146, 810-815.
34. Marks, F., and Furstenberger, G. (2000) Eur. J. Cancer, 36, 314-329.
35. Shureiqi, I., and Lippman, S. M. (2001) Cancer Res., 61, 6307-6312.
36. Brash, A. R. (1999) J. Biol. Chem., 274, 23679-23682.
37. Muller-Decker, K., Scholz, K., Neufang, G., Marks, F., and Furstenberger, G. (1998) Exp. Cell. Res., 242, 84-91.
38. Fischer, S. M. (2002) J. Environ. Pathol. Toxicol. Oncol., 21, 183-191.
39. Muller-Decker, K., Kopp-Schneider, A., Marks, F., Seibert, K., and Furstenberger, G. (1998) Mol. Carcinog., 23, 36-44.